Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Lenalidomide MeSH Descriptor Data 2026


MeSH Heading
Lenalidomide
Tree Number(s)
D02.241.223.805.810.400
D03.383.621.808.519
D03.633.100.513.750.563
Unique ID
D000077269
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077269
Scope Note
A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA.
Entry Term(s)
2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H- isoindol-2-yl)-
3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione
CC 5013
CC-5013
CC5013
IMiD3 Cpd
Revimid
Revlimid
Pharm Action
Immunologic Factors
Angiogenesis Inhibitors
Registry Numbers
F0P408N6V4
0
Related Numbers
191732-72-6
Public MeSH Note
2019; LENALIDOMIDE was indexed under THALIDOMIDE/analogs & derivatives 2002-2018
History Note
2019 (2002)
Date Introduced
2019/01/01
Last Updated
2019/01/01
Lenalidomide Preferred
CC 5013 Narrower
Revlimid Narrower
page delivered in 0.19s